Cardiometabolic risk comorbidities in exocrine pancreatic insufficiency compared to patients with cancer: A single centered observational retrospective cohort study.

Authors

null

James Peeples

Department of Internal Medicine, Ochsner Health, New Orleans, LA

James Peeples , James Gore , Karina G. Romo , Abdullah A. Noor , Gabriel I. Uwaifo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Quality of Care/Quality Improvement

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 642)

DOI

10.1200/JCO.2024.42.3_suppl.642

Abstract #

642

Poster Bd #

K11

Abstract Disclosures

Similar Posters

Poster

2017 Cancer Survivorship Symposium

Identifying Characteristics of Women Cancer Survivors with a Recent History of Falls.

Identifying Characteristics of Women Cancer Survivors with a Recent History of Falls.

First Author: Kerri M. Winters-Stone

Poster

2023 ASCO Annual Meeting

Plasma lipidomic profiling of chemotherapy-induced peripheral neuropathy.

Plasma lipidomic profiling of chemotherapy-induced peripheral neuropathy.

First Author: Nicole Yeung

Poster

2017 ASCO Annual Meeting

Chemotherapy-induced ovarian failure (CIOF) in young women with early breast cancer (EBC).

Chemotherapy-induced ovarian failure (CIOF) in young women with early breast cancer (EBC).

First Author: Jenny Furlanetto

Poster

2015 ASCO Annual Meeting

Death during study treatment: An evaluation of events in 31 German clinical trials.

Death during study treatment: An evaluation of events in 31 German clinical trials.

First Author: Jenny Furlanetto